Skip to main content

Written evidence

The antimicrobial potential of bacteriophages

Total results 40 (page 1 of 2)
CPI (PHA0047)
Centre for Phage Research at the University of Leicester (PHA0046)
UK Phage Therapy (PHA0045)
Dr Jean-Paul Pirnay (Head of the Laboratory of Molecular and Cellular Technology at Queen Astrid Military Hospital, Brussels) (PHA0044)
Ms Stephanie Lesage (CEO at Oxford Silk Phage Technologies Ltd) (PHA0043)
Naomi Zak (Co-Founder at BiomX) (PHA0042)
Virustatic Ltd (PHA0032)
Fixed Phage LTD (PHA0033)
University College London (UCL) (PHA0034)
Oxford Silk Phage Technologies Ltd (PHA0035)
Professor Tristan Ferry (Professor of Medicine at Hospices Civils de Lyon and Université Claude Bernard Lyon 1) (PHA0037)
Jason Clark (Chief Scientific Officer at Fixed Phage LTD) (PHA0038)
University of Nottingham, University of Nottingham, University of Nottingham, University of Nottingham, University of Nottingham, University of Nottingham, University of Nottingham, University of Nottingham, University of Nottingham, and University of Nottingham (PHA0039)
Great Ormond Street NHS Trust (PHA0040)
UKRI (PHA0041)
UK Phage Therapy (PHA0017)
Dr Josh Jones (Clinical Phage Specialist at NHS Tayside) (PHA0018)
Roslin Institute, University of Edinburgh (PHA0019)
Antibiotic Research UK (PHA0020)
Dr Gwen Knight (Associate Professor at London School of Hygiene and Tropical Medicine), and Prof Jodi Lindsay (Professor at St George's University of London) (PHA0021)
Total results 40 (page 1 of 2)